Gregory D. Davis serves as Executive at SANGAMO THERAPEUTICS, INC, where they oversee executive responsibilities. Since joining the company, Gregory D. Davis has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 25, 2026 involved selling 5,119 shares valued at $2.4K.
Gregory D. Davis currently holds 185,111 shares of SANGAMO THERAPEUTICS, INC (SGMO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory D. Davis has been a net neutral trader of SGMO stock. They have purchased $0 and sold $0 worth of shares.
Gregory D. Davis's most recent insider trade was on Feb 25, 2026, when they sold 5,119 shares at $0.47 per share.
Get notified when new Form 4 filings are submitted
| $0.47 |
| Discretionary |
| Jan 22, 2026 | SGMO | $3.1K | Payment | 7,721 | $0.40 | Discretionary |
| Nov 24, 2025 | SGMO | $304 | Payment | 723 | $0.42 | Discretionary |
| Oct 22, 2025 | SGMO | $4.4K | Payment | 6,708 | $0.66 | Discretionary |
| Aug 24, 2025 | SGMO | $427 | Payment | 723 | $0.59 | Discretionary |
| Jul 22, 2025 | SGMO | $3.2K | Payment | 6,708 | $0.48 | Discretionary |